Arena Pharmaceuticals, Inc.

NASDAQ: ARNA
$99.99
+$0.00 (+0.0%)
Closing Price on March 15, 2022

ARNA Articles

Angela Merkel goes into today’s EU summit at odds with other leaders about regionwide bonds and austerity. (Reuters) Barclays (NYSE: BCS) pays $453 million to settle a probe on Libor trading....
The three major US stock indexes opened modestly higher this morning as investors appear to have high hopes that tomorrow’s summit meeting of European Union leaders will lead to a resolution of the...
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is surging after the FDA approved its weight loss pill called BELVIQ.  In fact, now that shares have reopened after having been halted this stock is up a...
Each and every morning 24/7 Wall St. reviews the top analyst upgrades and downgrades from Wall Street analysts.  Some of these move stocks in a serious way while others sometimes miss the mark. ...
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday. ABB Ltd. (NYSE: ABB) Cut to Underweight at JPMorgan. Alaska Air Group...
How many big movers can you see in one day in the biotech sector?  This is what investors should be asking.  If you didn’t know better you might think there was a collusion in the biotech space...
The three major US stock indexes opened higher this morning as markets treated the Moody’s downgrade of 15 major banks as old news that was already baked into share prices (our coverage here and...
For today’s winners and losers, two of the four companies on the lists today are pharmaceutical companies, moving on action from drug regulators. One of them, Arena Pharmaceuticals, has seen its...
The three major US stock indexes opened lower this morning following European markets where equities also traded lower this morning. US data related to retail sales (our coverage here) and producer...
We are tracking and analyzing a significant volume spike in shares of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today.  Shares are up nearly 5% at $8.25 and the 12:30 PM trading volume is now over...
The major US stock indexes opened significantly lower this morning as investors reacted to the surprise loss of $2 billion by JPMorgan Chase & Co. (NYSE: JPM) disclosed by the bank’s CEO after...
These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Friday. Adtran Inc. (NASDAQ: ADTN) Reiterated Buy and $39 target at Argus. Apple Inc....
Facebook’s initial public offering is already oversubscribed. (Reuters) JP Morgan (NYSE: JPM) books a $2 billion trading loss, and the figure could rise by another $1 billion. (Reuters) China’s...
These are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Wednesday. American International Group, Inc. (NYSE: AIG) Raised to Buy at Goldman...
When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance of really setting the trend for the entire biotech sector this week. ...